Katherine E Brick1, Chad H Weaver1, Christine M Lohse2, Mark R Pittelkow3, Julia S Lehman4, Michael J Camilleri4, Mustafa Al-Hashimi1, Carilyn N Wieland5. 1. Department of Dermatology, Mayo Clinic, Rochester, Minnesota. 2. Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota. 3. Department of Dermatology, Mayo Clinic, Rochester, Minnesota; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota. 4. Department of Dermatology, Mayo Clinic, Rochester, Minnesota; Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota. 5. Department of Dermatology, Mayo Clinic, Rochester, Minnesota; Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota. Electronic address: wieland.carilyn@mayo.edu.
Abstract
BACKGROUND: Bullous pemphigoid (BP) is an autoimmune blistering disease that is associated with increased mortality. OBJECTIVE: We sought to determine the incidence and mortality of patients with BP. METHODS: A total of 87 residents of Olmsted County, Minnesota, were identified who had their first lifetime diagnosis of BP from January 1960 through December 2009. Incidence and mortality were compared with age- and sex-matched control patients from the same geographic area. RESULTS: The adjusted incidence of BP was 2.4 per 100,000 person-years (95% confidence interval, 1.9-2.9). Incidence of BP increased significantly with age (P < .001) and over time (P = .034). Trend tests indicate increased diagnosis of localized disease (P = .006) may be a contributing factor. Survival observed in the incident BP cohort was significantly poorer than expected (P < .001). Survival was not different among patients with multisite versus localized disease (P = .90). LIMITATIONS: Retrospective study design and study population from a small geographic area are limitations. CONCLUSION: Incidence of BP in the United States is comparable with that found in Europe and Asia. The mortality of BP is lower in the United States than Europe, but higher than previous estimates.
BACKGROUND: Bullous pemphigoid (BP) is an autoimmune blistering disease that is associated with increased mortality. OBJECTIVE: We sought to determine the incidence and mortality of patients with BP. METHODS: A total of 87 residents of Olmsted County, Minnesota, were identified who had their first lifetime diagnosis of BP from January 1960 through December 2009. Incidence and mortality were compared with age- and sex-matched control patients from the same geographic area. RESULTS: The adjusted incidence of BP was 2.4 per 100,000 person-years (95% confidence interval, 1.9-2.9). Incidence of BP increased significantly with age (P < .001) and over time (P = .034). Trend tests indicate increased diagnosis of localized disease (P = .006) may be a contributing factor. Survival observed in the incident BP cohort was significantly poorer than expected (P < .001). Survival was not different among patients with multisite versus localized disease (P = .90). LIMITATIONS: Retrospective study design and study population from a small geographic area are limitations. CONCLUSION: Incidence of BP in the United States is comparable with that found in Europe and Asia. The mortality of BP is lower in the United States than Europe, but higher than previous estimates.
Authors: A Gual; J M Mascaró; S Rojas-Farreras; A Guilabert; M Julià; P Iranzo Journal: J Eur Acad Dermatol Venereol Date: 2012-12-22 Impact factor: 6.166
Authors: P Joly; Ph Courville; C Lok; Ph Bernard; Ph Saiag; B Dreno; E Delaporte; C Bedane; C Picard; B Sassolas; P Plantin; M D'Incan; O Chosidow; C Pauwels; D Lambert; F Loche; C Prost; E Tancrede-Bohin; J C Guillaume; J C Roujeau; D Gilbert; F Tron; L Vaillant Journal: Dermatology Date: 2004 Impact factor: 5.366
Authors: P Bernard; L Vaillant; B Labeille; C Bedane; B Arbeille; J P Denoeux; G Lorette; J M Bonnetblanc; C Prost Journal: Arch Dermatol Date: 1995-01
Authors: Kelly N Messingham; Adam D Miller; Nandakumar S Narayanan; Samuel J Connell; Janet A Fairley Journal: J Invest Dermatol Date: 2019-03-12 Impact factor: 8.551
Authors: B J Barrick; J D Barrick; C H Weaver; C M Lohse; C N Wieland; A N Kalaaji; J S Lehman Journal: Br J Dermatol Date: 2016-02-04 Impact factor: 9.302
Authors: Katherine E Brick; Chad H Weaver; Rodolfo Savica; Christine M Lohse; Mark R Pittelkow; Bradley F Boeve; Lawrence E Gibson; Michael J Camilleri; Carilyn N Wieland Journal: J Am Acad Dermatol Date: 2014-08-29 Impact factor: 11.527